These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 16669416

  • 1. Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication.
    Hiatt WR, Krantz MJ.
    Vasc Med; 2006 Feb; 11(1):55-60. PubMed ID: 16669416
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Optimal medical management of peripheral arterial disease.
    Rice TW, Lumsden AB.
    Vasc Endovascular Surg; 2006 Feb; 40(4):312-27. PubMed ID: 16959725
    [Abstract] [Full Text] [Related]

  • 5. Management of peripheral arterial disease and intermittent claudication.
    Schainfeld RM.
    J Am Board Fam Pract; 2001 Feb; 14(6):443-50. PubMed ID: 11757887
    [Abstract] [Full Text] [Related]

  • 6. Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease.
    Cavendish JJ, Safani M.
    Curr Med Res Opin; 2004 Nov; 20(11):1851-5. PubMed ID: 15537486
    [Abstract] [Full Text] [Related]

  • 7. Pharmacologic therapy for peripheral arterial disease and claudication.
    Hiatt WR.
    J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Management of peripheral arterial disease.
    Aronow WS.
    Cardiol Rev; 2005 Dec; 13(2):61-8. PubMed ID: 15705252
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rationale for the use of platelet aggregation inhibitors in PAD patients.
    Agnelli G.
    Vasc Med; 2001 Dec; 6(3 Suppl):13-5. PubMed ID: 11789961
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
    Khan S, Flather M, Mister R, Delahunty N, Fowkes G, Bradbury A, Stansby G.
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
    [Abstract] [Full Text] [Related]

  • 14. [Role of antiaggregants in the treatment of arterial diseases of the lower limbs].
    Boissel JP.
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1721-4. PubMed ID: 1837446
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Drug treatment of peripheral arterial disease in the elderly.
    Aronow WS.
    Drugs Aging; 2006 Nov; 23(1):1-12. PubMed ID: 16492065
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease.
    Di Minno G, Spadarella G, Cafaro G, Petitto M, Lupoli R, Di Minno A, de Gaetano G, Tremoli E.
    Ann Med; 2014 Nov; 46(7):475-89. PubMed ID: 25045928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.